IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
122.4 EUR
+0.6 (+0.49%)
Overall IPN gets a fundamental rating of 6 out of 10. We evaluated IPN against 55 industry peers in the Pharmaceuticals industry. IPN has an excellent financial health rating, but there are some minor concerns on its profitability. IPN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IPN had positive earnings in the past year.
In the past year IPN had a positive cash flow from operations.
IPN had positive earnings in each of the past 5 years.
IPN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
IPN has a Return On Assets of 6.56%. This is comparable to the rest of the industry: IPN outperforms 58.18% of its industry peers.
IPN has a Return On Equity (10.59%) which is in line with its industry peers.
With a decent Return On Invested Capital value of 14.88%, IPN is doing good in the industry, outperforming 76.36% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IPN is in line with the industry average of 13.92%.
The 3 year average ROIC (12.97%) for IPN is below the current ROIC(14.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
IPN has a Profit Margin (11.91%) which is in line with its industry peers.
IPN's Profit Margin has declined in the last couple of years.
IPN has a Operating Margin of 26.01%. This is in the better half of the industry: IPN outperforms 61.82% of its industry peers.
In the last couple of years the Operating Margin of IPN has declined.
The Gross Margin of IPN (83.32%) is better than 89.09% of its industry peers.
In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
The number of shares outstanding for IPN has been increased compared to 1 year ago.
IPN has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for IPN has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.48 indicates that IPN is not in any danger for bankruptcy at the moment.
IPN's Altman-Z score of 4.48 is fine compared to the rest of the industry. IPN outperforms 67.27% of its industry peers.
The Debt to FCF ratio of IPN is 1.69, which is an excellent value as it means it would take IPN, only 1.69 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.69, IPN belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, IPN is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.48 |
ROIC/WACC1.91
WACC7.8%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.98, IPN is doing good in the industry, outperforming 72.73% of the companies in the same industry.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.80, IPN belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
The Revenue has grown by 9.45% in the past year. This is quite good.
The Revenue has been growing slightly by 5.83% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
The Earnings Per Share is expected to grow by 5.58% on average over the next years.
The Revenue is expected to grow by 4.58% on average over the next years.
EPS Next Y6.71%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPS Next 5Y5.58%
Revenue Next Year8.23%
Revenue Next 2Y6.1%
Revenue Next 3Y6%
Revenue Next 5Y4.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.92 indicates a reasonable valuation of IPN.
74.55% of the companies in the same industry are more expensive than IPN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.41, IPN is valued rather cheaply.
A Price/Forward Earnings ratio of 11.06 indicates a reasonable valuation of IPN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 72.73% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.40, IPN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.92 | ||
| Fwd PE | 11.06 |
4.2 Price Multiples
IPN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IPN is cheaper than 96.36% of the companies in the same industry.
65.45% of the companies in the same industry are more expensive than IPN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.89 | ||
| EV/EBITDA | 5.75 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)1.78
PEG (5Y)1.36
EPS Next 2Y3.8%
EPS Next 3Y4.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.13%, IPN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.86, IPN has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, IPN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPA:IPN (12/4/2025, 7:00:00 PM)
122.4
+0.6 (+0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.12%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.26B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts70
Price Target132.68 (8.4%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.13% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.99%
PT rev (3m)2.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.44%
EPS NY rev (3m)5.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.09%
Revenue NY rev (3m)1.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.92 | ||
| Fwd PE | 11.06 | ||
| P/S | 2.73 | ||
| P/FCF | 19.89 | ||
| P/OCF | 11.43 | ||
| P/B | 2.43 | ||
| P/tB | 7.68 | ||
| EV/EBITDA | 5.75 |
EPS(TTM)10.27
EY8.39%
EPS(NY)11.07
Fwd EY9.04%
FCF(TTM)6.15
FCFY5.03%
OCF(TTM)10.71
OCFY8.75%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)1.78
PEG (5Y)1.36
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.48 |
F-Score7
WACC7.8%
ROIC/WACC1.91
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y6.71%
EPS Next 2Y3.8%
EPS Next 3Y4.44%
EPS Next 5Y5.58%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year8.23%
Revenue Next 2Y6.1%
Revenue Next 3Y6%
Revenue Next 5Y4.58%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year32.82%
EBIT Next 3Y13.53%
EBIT Next 5Y7.89%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 6.71% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.